GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation
OSL:GENT • NO0010748866
39 NOK
-0.5 (-1.27%)
Last: Mar 6, 2026, 07:00 PM
This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 7 out of 10 to GENT. GENT was compared to 63 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make GENT suitable for growth investing!
1. GENT.OL Profitability Analysis
1.1 Basic Checks
- In the past year GENT was profitable.
- GENT had a positive operating cash flow in the past year.
- In multiple years GENT reported negative net income over the last 5 years.
- In multiple years GENT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- The Return On Assets of GENT (18.38%) is better than 96.83% of its industry peers.
- GENT has a Return On Equity of 21.18%. This is amongst the best in the industry. GENT outperforms 90.48% of its industry peers.
- GENT has a better Return On Invested Capital (8.76%) than 73.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.38% | ||
| ROE | 21.18% | ||
| ROIC | 8.76% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GENT has a better Profit Margin (24.80%) than 95.24% of its industry peers.
- With a decent Operating Margin value of 13.44%, GENT is doing good in the industry, outperforming 60.32% of the companies in the same industry.
- Looking at the Gross Margin, with a value of 55.06%, GENT is in line with its industry, outperforming 46.03% of the companies in the same industry.
- In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.44% | ||
| PM (TTM) | 24.8% | ||
| GM | 55.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. GENT.OL Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
- GENT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 13.02 indicates that GENT is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 13.02, GENT belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
- GENT has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
- GENT's Debt to FCF ratio of 0.59 is amongst the best of the industry. GENT outperforms 95.24% of its industry peers.
- A Debt/Equity ratio of 0.01 indicates that GENT is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.01, GENT belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 13.02 |
ROIC/WACC1.03
WACC8.48%
2.3 Liquidity
- GENT has a Current Ratio of 5.98. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of GENT (5.98) is better than 98.41% of its industry peers.
- GENT has a Quick Ratio of 4.16. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT has a Quick ratio of 4.16. This is amongst the best in the industry. GENT outperforms 96.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.98 | ||
| Quick Ratio | 4.16 |
3. GENT.OL Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 2066.40% over the past year.
- GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.42%.
- The Revenue has been growing by 25.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
3.2 Future
- Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 62.29% on average per year.
- The Revenue is expected to grow by 20.47% on average over the next years. This is a very strong growth
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.87%
Revenue Next 2Y19.6%
Revenue Next 3Y20.47%
Revenue Next 5YN/A
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. GENT.OL Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 14.29, which indicates a correct valuation of GENT.
- Based on the Price/Earnings ratio, GENT is valued cheaply inside the industry as 95.24% of the companies are valued more expensively.
- GENT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.29.
- GENT is valuated correctly with a Price/Forward Earnings ratio of 14.37.
- GENT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. GENT is cheaper than 77.78% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, GENT is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.29 | ||
| Fwd PE | 14.37 |
4.2 Price Multiples
- GENT's Enterprise Value to EBITDA is on the same level as the industry average.
- 63.49% of the companies in the same industry are cheaper than GENT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 185.1 | ||
| EV/EBITDA | 16.27 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. GENT.OL Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.52%, GENT has a reasonable but not impressive dividend return.
- In the last 3 months the price of GENT has falen by -28.83%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- Compared to an average industry Dividend Yield of 1.06, GENT pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, GENT has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.52% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
GENT.OL Fundamentals: All Metrics, Ratios and Statistics
OSL:GENT (3/6/2026, 7:00:00 PM)
39
-0.5 (-1.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap601.38M
Revenue(TTM)172.52M
Net Income(TTM)42.78M
Analysts85.71
Price Target64.26 (64.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.52% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.59%
Revenue NY rev (3m)-8.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.29 | ||
| Fwd PE | 14.37 | ||
| P/S | 3.49 | ||
| P/FCF | 185.1 | ||
| P/OCF | 48.5 | ||
| P/B | 2.98 | ||
| P/tB | 3.54 | ||
| EV/EBITDA | 16.27 |
EPS(TTM)2.73
EY7%
EPS(NY)2.71
Fwd EY6.96%
FCF(TTM)0.21
FCFY0.54%
OCF(TTM)0.8
OCFY2.06%
SpS11.19
BVpS13.1
TBVpS11.01
PEG (NY)0.24
PEG (5Y)N/A
Graham Number28.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.38% | ||
| ROE | 21.18% | ||
| ROCE | 11.37% | ||
| ROIC | 8.76% | ||
| ROICexc | 15.22% | ||
| ROICexgc | 21.01% | ||
| OM | 13.44% | ||
| PM (TTM) | 24.8% | ||
| GM | 55.06% | ||
| FCFM | 1.88% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.06 | ||
| Cap/Depr | 101.32% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 38.48% | ||
| Profit Quality | 7.6% | ||
| Current Ratio | 5.98 | ||
| Quick Ratio | 4.16 | ||
| Altman-Z | 13.02 |
F-Score5
WACC8.48%
ROIC/WACC1.03
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
Revenue Next Year19.87%
Revenue Next 2Y19.6%
Revenue Next 3Y20.47%
Revenue Next 5YN/A
EBIT growth 1Y260.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year169.23%
EBIT Next 3Y84.01%
EBIT Next 5Y65.28%
FCF growth 1Y127.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.08%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
How financially healthy is GENTIAN DIAGNOSTICS ASA?
The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 59.41% in the next year.